AVEO PHARMACEUTICALS INC (AVEO)

US0535883070 - Common Stock

15  0 (0%)

After market: 15 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024
Revenue
YoY % growth
28.8M
433.33%		6M
-79.17%		42.295M
604.92%		114.29M
170.22%
EBITDA
YoY % growth
N/A-38.88M-49.487M
-27.28%		N/AN/AN/A
EBIT
YoY % growth
-400K
98.47%		-38.9M
-9,625.00%		-49.554M
-27.39%		-19.178M
61.30%
Operating Margin
-1.39%-648.33%-117.16%-16.78%
EPS
YoY % growth
0.62
224.00%		-1.71
-375.81%		-1.72
-0.58%		-0.69
59.87%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 22
EPS
Q2Q % growth		-0.05
77.33%
Revenue
Q2Q % growth		36.075M
104.44%
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-1.476M
76.05%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth		 -0.09
70.00%		-0.180.0949.87%
Q2 2022
Q2Q % growth		 -0.24
40.00%		-0.290.0515.97%
Q1 2022
Q2Q % growth		 -0.30
62.96%		-0.25-0.05-18.60%
Q4 2021
Q2Q % growth		 -0.21
52.27%		-0.290.0828.39%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth		 30.449M
100.68%		30.14M309K1.03%
Q2 2022
Q2Q % growth		 25.304M
234.89%		25.845M-541K-2.09%
Q1 2022
Q2Q % growth		 20.92M
1,001.05%		21.064M-144K-0.68%
Q4 2021
Q2Q % growth		 17.646M
1,860.67%		18.293M-647K-3.54%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 56.59% 0% 10.67%
Revenue0% 2.59% 0% 1.76%